Warren E. Ross

4.7k total citations · 2 hit papers
56 papers, 4.2k citations indexed

About

Warren E. Ross is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Warren E. Ross has authored 56 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 15 papers in Organic Chemistry and 15 papers in Oncology. Recurrent topics in Warren E. Ross's work include Cancer therapeutics and mechanisms (40 papers), DNA and Nucleic Acid Chemistry (12 papers) and Synthesis and Biological Evaluation (9 papers). Warren E. Ross is often cited by papers focused on Cancer therapeutics and mechanisms (40 papers), DNA and Nucleic Acid Chemistry (12 papers) and Synthesis and Biological Evaluation (9 papers). Warren E. Ross collaborates with scholars based in United States, Canada and Czechia. Warren E. Ross's co-authors include Bonnie S. Glisson, Kurt W. Kohn, Richard B. Lock, Daniel Glaubiger, Kuan‐Chih Chow, Jack C. Yalowich, Daniel M. Sullivan, Antoinette J. Wozniak, Leroy F. Liu and Matthews O. Bradley and has published in prestigious journals such as Genes & Development, Molecular and Cellular Biology and Biochemistry.

In The Last Decade

Warren E. Ross

56 papers receiving 3.9k citations

Hit Papers

Role of topoisomerase II ... 1979 2026 1994 2010 1984 1979 100 200 300

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Warren E. Ross 3.4k 1.7k 667 546 355 56 4.2k
Thomas C. Rowe 3.2k 1.0× 1.2k 0.7× 691 1.0× 593 1.1× 299 0.8× 44 4.2k
K M Tewey 3.3k 1.0× 1.4k 0.9× 712 1.1× 752 1.4× 217 0.6× 7 3.9k
Philippe Pourquier 3.2k 0.9× 1.5k 0.9× 502 0.8× 602 1.1× 488 1.4× 108 4.6k
Giovanni Capranico 4.9k 1.4× 2.0k 1.2× 1.0k 1.6× 948 1.7× 524 1.5× 144 6.2k
Christopher K. Mirabelli 2.8k 0.8× 2.1k 1.3× 1.3k 2.0× 361 0.7× 146 0.4× 73 4.6k
William T. Beck 5.3k 1.6× 4.2k 2.5× 560 0.8× 429 0.8× 626 1.8× 131 7.4k
Bridget T. Hill 3.0k 0.9× 2.2k 1.3× 555 0.8× 180 0.3× 551 1.6× 193 5.3k
Peter Charlton 2.7k 0.8× 2.1k 1.3× 602 0.9× 198 0.4× 628 1.8× 74 4.5k
Glenda Kohlhagen 4.1k 1.2× 1.9k 1.1× 1.3k 2.0× 1.1k 2.1× 564 1.6× 70 5.3k
Joseph M. Covey 2.4k 0.7× 802 0.5× 320 0.5× 347 0.6× 253 0.7× 88 3.0k

Countries citing papers authored by Warren E. Ross

Since Specialization
Citations

This map shows the geographic impact of Warren E. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren E. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren E. Ross more than expected).

Fields of papers citing papers by Warren E. Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warren E. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren E. Ross. The network helps show where Warren E. Ross may publish in the future.

Co-authorship network of co-authors of Warren E. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Warren E. Ross. A scholar is included among the top collaborators of Warren E. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warren E. Ross. Warren E. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lazar, Amanda, et al.. (2021). How Content Authored by People with Dementia Affects Attitudes towards Dementia. Proceedings of the ACM on Human-Computer Interaction. 5(CSCW2). 1–32. 8 indexed citations
2.
Glisson, Bonnie S., et al.. (1992). Dissociation of cytotoxicity and DNA cleavage activity induced by topoisomerase II-reactive intercalating agents in hamster-human somatic cell hybrids. Cancer Chemotherapy and Pharmacology. 31(2). 131–138. 5 indexed citations
3.
Sullivan, Daniel M. & Warren E. Ross. (1991). Resistance to inhibitors of DNA topoisomerases. Cancer treatment and research. 57. 57–99. 17 indexed citations
4.
Lock, Richard B. & Warren E. Ross. (1990). Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells.. PubMed. 50(12). 3761–6. 202 indexed citations
5.
Lock, Richard B. & Warren E. Ross. (1990). Possible role for p34cdc2 kinase in etoposide-induced cell death of Chinese hamster ovary cells.. PubMed. 50(12). 3767–71. 83 indexed citations
6.
Subjeck, John R., et al.. (1989). Depletion of Topoisomerase II in Isolated Nuclei during a Glucose-Regulated Stress Response. Molecular and Cellular Biology. 9(8). 3284–3291. 3 indexed citations
7.
Sullivan, Daniel M., et al.. (1989). Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell line. Biochemistry. 28(13). 5680–5687. 81 indexed citations
8.
Latham, Michael D., et al.. (1989). Inhibition of topoisomerases by fredericamycin A. Cancer Chemotherapy and Pharmacology. 24(3). 167–171. 26 indexed citations
9.
Chow, Kuan‐Chih, T. L. MACDONALD, & Warren E. Ross. (1988). DNA binding by epipodophyllotoxins and N-acyl anthracyclines: implications for mechanism of topoisomerase II inhibition.. Molecular Pharmacology. 34(4). 467–473. 93 indexed citations
10.
Sullivan, Dan M., et al.. (1987). Mechanisms of resistance to topoisomerase ii active drugs. Breast Cancer Research and Treatment. 10(1). 120. 1 indexed citations
11.
Chow, Kuan‐Chih & Warren E. Ross. (1987). Topoisomerase-Specific Drug Sensitivity in Relation to Cell Cycle Progression. Molecular and Cellular Biology. 7(9). 3119–3123. 32 indexed citations
12.
Rowe, Thomas C., Gary M. Kupfer, & Warren E. Ross. (1985). Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavage. Biochemical Pharmacology. 34(14). 2483–2487. 93 indexed citations
13.
Singh, Gurmit, et al.. (1985). A method for assessing damage to mitochondrial DNA caused by radiation and epichlorohydrin.. Molecular Pharmacology. 27(1). 167–168. 25 indexed citations
14.
Phillips, Gordon L., Joseph W. Fay, Geoffrey P. Herzig, et al.. (1983). Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer a phase I-II study. Cancer. 52(10). 1792–1802. 107 indexed citations
15.
Altmaier, Elizabeth M., Warren E. Ross, & Kate Moore. (1982). A pilot investigation of the psychologic functioning of patients with anticipatory vomiting. Cancer. 49(1). 201–204. 36 indexed citations
16.
Ross, Warren E., et al.. (1981). Cytotoxicity and deoxyribonucleic acid damage associated with bromoacetate. Biochemical Pharmacology. 30(12). 1497–1500. 4 indexed citations
17.
Ross, Warren E., et al.. (1981). A mammalian topoisomerase--possible relationship to intercalator-induced dna strand breakage. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 243. 2 indexed citations
18.
Shackney, Stanley E., et al.. (1980). A study of drug-induced kinetic perturbations in the marrow of a patient with neuroblastoma. Cancer. 45(5). 882–892. 3 indexed citations
19.
Ross, Warren E., Daniel Glaubiger, & Kurt W. Kohn. (1979). Qualitative and quantitative aspects of intercalator-induced DNA strand breaks. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 562(1). 41–50. 216 indexed citations breakdown →
20.
Triche, Timothy J. & Warren E. Ross. (1978). Glycogen-containing neuroblastoma with clinical and histopathologic features of Ewing's sarcoma. Cancer. 41(4). 1425–1432. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026